Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 7/2003

01-11-2003

The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium

Authors: Chang Dae Ko, Jee Soo Kim, Byung Gyun Ko, Byung Ho Son, Hee Joon Kang, Ho Sung Yoon, Eun Yoon Cho, Gyungyub Gong, Sei Hyun Ahn

Published in: Clinical & Experimental Metastasis | Issue 7/2003

Login to get access
Metadata
Title
The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium
Authors
Chang Dae Ko
Jee Soo Kim
Byung Gyun Ko
Byung Ho Son
Hee Joon Kang
Ho Sung Yoon
Eun Yoon Cho
Gyungyub Gong
Sei Hyun Ahn
Publication date
01-11-2003
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 7/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1023/A:1027323210736

Other articles of this Issue 7/2003

Clinical & Experimental Metastasis 7/2003 Go to the issue

OriginalPaper

Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor

OriginalPaper

Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells

OriginalPaper

Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase

OriginalPaper

Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells

OriginalPaper

Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma

OriginalPaper

IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-α and DTIC
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits